🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jessica N. Hatton

National Cancer Institute

ORCID: 0000-0003-2104-171X

Also affiliated with Department of Health and Human Services

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
4.3Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute

Cell Death and Differentiation(2022)10.1038/s41418-022-00976-3
Top 6%
4.0DataRank
Top 6%167 citations

Elaine E. Lee, Elise M. Tookmanian, Chimene Kesserwan, James J. Manfredi, Jessica N. Hatton +12 more

Papers

Driven by 11 papers — median percentile 72. Top paper: “The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute”.

The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute

Cell Death and Differentiation(2022)10.1038/s41418-022-00976-3
Top 6%
4.0DataRank
Top 6%167 citations

Elaine E. Lee, Elise M. Tookmanian, Chimene Kesserwan, James J. Manfredi, Jessica N. Hatton +12 more

Specifications of the ACMG/AMP Variant Classification Guidelines for Germline DICER1 Variant Curation

Human Mutation(2023)10.1155/2023/9537832
N/A
0.746DataRank · unranked
15 citations

Megan N. Frone, Hannah C. Cox, Stephanie B. Crowley, Susan Hiraki, Noriko N. Yokoyama +20 more

A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.0112
N/A
0.578DataRank · unranked
46 citations

Jung Kim, Ana F. Best, Zongming E. Chen, Ying Hu, Jeremy S. Haley +15 more

Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants

Human Genetics and Genomics Advances(2023)10.1016/j.xhgg.2023.100242
N/A
0.449DataRank · unranked
19 citations

Natasha T. Strande, Jung Kim, Jeremy S. Haley, Jessica N. Hatton, Megan N. Frone +13 more

A genome-first approach to characterize DICER1 pathogenic variant prevalence, penetrance and cancer, thyroid, and other phenotypes in 2 population-scale cohorts

Genetics in Medicine Open(2024)10.1016/j.gimo.2024.101846
Top 50%
0.355DataRank
Top 50%9 citations

Jeremy S. Haley, Jessica N. Hatton, Uyenlinh L Mirshahi, H. Shanker Rao, Mark Ramos +6 more

Clinicopathologic Features, Management, and Outcomes Of Pediatric CRTC1::TRIM11 and MED15::ATF1 Tumors With Spitzoid Morphology: A Case Series

Pediatric Blood & Cancer(2025)10.1002/pbc.31814
N/A
0.330DataRank · unranked
8 citations

Madeline H. Fitzhugh, Jennifer S. Ko, Allison Close, Sara C. Horton, Faizan Malik +26 more

Spectrum and Incidence of Skin Cancer among Individuals with Li-Fraumeni Syndrome

Journal of Investigative Dermatology(2022)10.1016/j.jid.2022.02.004
N/A
0.292DataRank · unranked
6 citations

Michael R. Sargen, Megan N. Frone, Kelvin C. de Andrade, Sharon A. Savage, Payal P. Khincha +1 more

A quantitative, Bayesian-informed approach to gene-specific variant classification: Updated Expert Panel recommendations improve classification of TP53 germline variants for Li-Fraumeni syndrome

Genome Medicine(2025)10.1186/s13073-025-01536-3
N/A
0.269DataRank · unranked
5 citations

Megan N. Frone, Jessica L. Mester, Miguel de la Hoya, Phuong L. Mai, Tina Pesaran +32 more

DICER1-Related Tumor Predisposition: Identification of At-risk Individuals and Recommended Surveillance Strategies

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1532
N/A
0DataRank · unranked
29 citations

Alexander T. Nelson, Paige Mallinger, Anne K. Harris, Junne Kamihara, Shari Baldinger +26 more

Spectrum and Excess Risk of Gastrointestinal Tumors in Li-Fraumeni Syndrome

Clinical Gastroenterology and Hepatology(2023)10.1016/j.cgh.2023.08.028
N/A
0DataRank · unranked
9 citations

Kelvin C. de Andrade, Megan N. Frone, Sharon A. Savage, Payal P. Khincha, Jessica N. Hatton

Characterization of sarcoma topography in Li-Fraumeni syndrome

Frontiers in Oncology(2024)10.3389/fonc.2024.1415636
N/A
0DataRank · unranked
3 citations

M.B. Thompson, Lisa Mirabello, Sharon Savage, Ashkan A. Malayeri, Jessica N. Hatton +2 more